Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Cofetuzumab pelidotin

😃Good
Catalog No. T9901A-055Cas No. 1869937-48-3

Cofetuzumab pelidotin (PF-06647020) is an antibody-drug conjugate (ADC) targeting PTK7, composed of the humanized anti-PTK7 monoclonal antibody (hu6M024, IgG1) linked to the auristatin-based microtubule inhibitor payload, auristatin-0101 (Aur0101), via a cleavable valine-citrulline (vc)-based linker. This compound exhibits a drug-to-antibody ratio (DAR) of 4 and selectively binds to cell-surface PTK7 with an EC50 of 1153 pM as determined by flow cytometry. Cofetuzumab pelidotin holds promise for the study of solid tumors [1] [2] [3].

Cofetuzumab pelidotin

Cofetuzumab pelidotin

😃Good
Catalog No. T9901A-055Cas No. 1869937-48-3
Cofetuzumab pelidotin (PF-06647020) is an antibody-drug conjugate (ADC) targeting PTK7, composed of the humanized anti-PTK7 monoclonal antibody (hu6M024, IgG1) linked to the auristatin-based microtubule inhibitor payload, auristatin-0101 (Aur0101), via a cleavable valine-citrulline (vc)-based linker. This compound exhibits a drug-to-antibody ratio (DAR) of 4 and selectively binds to cell-surface PTK7 with an EC50 of 1153 pM as determined by flow cytometry. Cofetuzumab pelidotin holds promise for the study of solid tumors [1] [2] [3].
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mgInquiryInquiryInquiry
5 mgInquiryInquiryInquiry
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Cofetuzumab pelidotin (PF-06647020) is an antibody-drug conjugate (ADC) targeting PTK7, composed of the humanized anti-PTK7 monoclonal antibody (hu6M024, IgG1) linked to the auristatin-based microtubule inhibitor payload, auristatin-0101 (Aur0101), via a cleavable valine-citrulline (vc)-based linker. This compound exhibits a drug-to-antibody ratio (DAR) of 4 and selectively binds to cell-surface PTK7 with an EC50 of 1153 pM as determined by flow cytometry. Cofetuzumab pelidotin holds promise for the study of solid tumors [1] [2] [3].
In vitro
Cofetuzumab pelidotin (PF-06647020) exhibits cytotoxic effects in vitro against PTK7-expressing cancer cell lines H446, H661, and OVCAR3, with EC50 values of 7.6, 27.5, and 105 ng/mL, respectively[1]. Over a duration of six days, it shows high potency and PTK7-specific cytotoxicity in a range of cancer cell lines (A549, MDA-MB-468, KYSE-150, SKOV-3, PC9, NCI-H1975), with IC50 values ranging from 0 to 1100 nM[2]. However, its stability is relatively poor, with a T1/2 of less than 3 days[2].
In vivo
Cofetuzumab pelidotin (PF-06647020; 3 mg/kg; intraperitoneal injection twice weekly for four cycles) demonstrated significant in vivo antitumor activity in patient-derived xenograft (PDX) models of NSCLC, OVCA, and TNBC [1]. The study utilized NOD scid mice aged 6 to 10 weeks, harboring cells from these cancers [1]. The findings confirm that the specified dosage and administration route effectively suppress these tumor cells.
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
Endotoxin< 1.0 EU/mg
Antigen Details
TargetPTK7
Chemical Properties
Cas No.1869937-48-3
Storage & Solubility Information
Storage-20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Cofetuzumab pelidotin | purchase Cofetuzumab pelidotin | Cofetuzumab pelidotin cost | order Cofetuzumab pelidotin | Cofetuzumab pelidotin in vivo | Cofetuzumab pelidotin in vitro